Accounts Payable, Current of Neuphoria Therapeutics Inc. from 30 Jun 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Neuphoria Therapeutics Inc. quarterly Accounts Payable, Current in USD history and change rate from 30 Jun 2023 to 31 Dec 2025.
  • Neuphoria Therapeutics Inc. Accounts Payable, Current for the quarter ending 31 Dec 2025 was $520,709, a 66% decline year-over-year.
Source SEC data
View on sec.gov
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Accounts Payable, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $520,709 -$1,009,958 -66% 31 Dec 2025 10-Q 17 Feb 2026 2025 Q2
Q3 2025 $1,370,728 +$44,734 +3.4% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q1
Q2 2025 $1,154,369 -$1,089,293 -49% 30 Jun 2025 10-Q 17 Feb 2026 2025 Q2
Q1 2025 $745,336 31 Mar 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 $1,530,667 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2
Q3 2024 $1,325,994 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $2,243,662 +$804,371 +56% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $1,439,291 30 Jun 2023 10-K 30 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.